APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-Acting Contraceptive Pills

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Long-Acting Contraceptive Pills Industry Growth and Trends Forecast to 2032

28 December 202599 pages

Choose your research edition.

Industry ResearchLong-Acting Contraceptive Pills Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Acting Contraceptive Pills Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Long-Acting Contraceptive Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Acting Contraceptive Pills Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Acting Contraceptive Pills Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Long-Acting Contraceptive Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-Acting Contraceptive Pills include Bayer, Cipla, Merck, Sun Pharma, Teva Pharmaceuticals, Pfizer, Mylan, Shanghai Pharmaceuticals and Zhejiang Xianju Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Long-Acting Contraceptive Pills market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Long-Acting Contraceptive Pills market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Long-Acting Contraceptive Pills market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Long-Acting Contraceptive Pills.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Long-Acting Contraceptive Pills market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Long-Acting Contraceptive Pills Market by Company

Bayer

Cipla

Merck

Sun Pharma

Teva Pharmaceuticals

Pfizer

Mylan

Shanghai Pharmaceuticals

Zhejiang Xianju Pharmaceutical

Long-Acting Contraceptive Pills Segment by Type

Injectables

Subdermal Implants

Intrauterine Devices

Other

Long-Acting Contraceptive Pills Segment by Application

Hospital

Clinic

Long-Acting Contraceptive Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Contraceptive Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-Acting Contraceptive Pills manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Long-Acting Contraceptive Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectables Table 2. Major Company of Subdermal Implants Table 3. Major Company of Intrauterine Devices Table 4. Major Company of Other Table 5. Global Long-Acting Contraceptive Pills Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 7. Global Long-Acting Contraceptive Pills Sales Market Share in Volume by Type (2021-2026) Table 8. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (US$ Million) Table 9. Global Long-Acting Contraceptive Pills Sales Market Share in Value by Type (2021-2026) Table 10. Global Long-Acting Contraceptive Pills Price by Type (2021-2026) & (US$/Unit) Table 11. Global Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 12. Global Long-Acting Contraceptive Pills Sales Market Share in Volume by Type (2027-2032) Table 13. Global Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (US$ Million) Table 14. Global Long-Acting Contraceptive Pills Sales Market Share in Value by Type (2027-2032) Table 15. Global Long-Acting Contraceptive Pills Price by Type (2027-2032) & (US$/Unit) Table 16. North America Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 17. North America Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 19. Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 23. Latin America Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (US$ Million) Table 26. Long-Acting Contraceptive Pills Industry Trends Table 27. Long-Acting Contraceptive Pills Industry Drivers Table 28. Long-Acting Contraceptive Pills Industry Opportunities and Challenges Table 29. Long-Acting Contraceptive Pills Industry Restraints Table 30. Global Long-Acting Contraceptive Pills Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Long-Acting Contraceptive Pills Revenue Market Share by Company (2021-2026) Table 32. Global Long-Acting Contraceptive Pills Sales by Company (2021-2026) & (K Units) Table 33. Global Long-Acting Contraceptive Pills Sales Share by Company (2021-2026) Table 34. Global Long-Acting Contraceptive Pills Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Long-Acting Contraceptive Pills Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Long-Acting Contraceptive Pills Major Company Production Sites and Headquarters Table 37. Global Long-Acting Contraceptive Pills Company, Product Type & Application Table 38. Global Long-Acting Contraceptive Pills Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Long-Acting Contraceptive Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Long-Acting Contraceptive Pills Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (K Units) Table 43. Global Long-Acting Contraceptive Pills Sales Market Share in Volume by Region (2021-2026) Table 44. Global Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (US$ Million) Table 45. Global Long-Acting Contraceptive Pills Sales Market Share in Value by Region (2021-2026) Table 46. Global Long-Acting Contraceptive Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Long-Acting Contraceptive Pills Sales by Region (2027-2032) & (K Units) Table 48. Global Long-Acting Contraceptive Pills Sales Market Share in Volume by Region (2027-2032) Table 49. Global Long-Acting Contraceptive Pills Sales by Region (2027-2032) & (US$ Million) Table 50. Global Long-Acting Contraceptive Pills Sales Market Share in Value by Region (2027-2032) Table 51. Global Long-Acting Contraceptive Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Long-Acting Contraceptive Pills Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 54. Global Long-Acting Contraceptive Pills Sales Market Share in Volume by Application (2021-2026) Table 55. Global Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (US$ Million) Table 56. Global Long-Acting Contraceptive Pills Sales Market Share in Value by Application (2021-2026) Table 57. Global Long-Acting Contraceptive Pills Price by Application (2021-2026) & (US$/Unit) Table 58. Global Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 59. Global Long-Acting Contraceptive Pills Sales Market Share in Volume by Application (2027-2032) Table 60. Global Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (US$ Million) Table 61. Global Long-Acting Contraceptive Pills Sales Market Share in Value by Application (2027-2032) Table 62. Global Long-Acting Contraceptive Pills Price by Application (2027-2032) & (US$/Unit) Table 63. North America Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 64. North America Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 66. Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 70. Latin America Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (US$ Million) Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Bayer Long-Acting Contraceptive Pills Product Portfolio Table 77. Bayer Recent Development Table 78. Cipla Company Information Table 79. Cipla Business Overview Table 80. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cipla Long-Acting Contraceptive Pills Product Portfolio Table 82. Cipla Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Long-Acting Contraceptive Pills Product Portfolio Table 87. Merck Recent Development Table 88. Sun Pharma Company Information Table 89. Sun Pharma Business Overview Table 90. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sun Pharma Long-Acting Contraceptive Pills Product Portfolio Table 92. Sun Pharma Recent Development Table 93. Teva Pharmaceuticals Company Information Table 94. Teva Pharmaceuticals Business Overview Table 95. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 97. Teva Pharmaceuticals Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Long-Acting Contraceptive Pills Product Portfolio Table 102. Pfizer Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Mylan Long-Acting Contraceptive Pills Product Portfolio Table 107. Mylan Recent Development Table 108. Shanghai Pharmaceuticals Company Information Table 109. Shanghai Pharmaceuticals Business Overview Table 110. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 112. Shanghai Pharmaceuticals Recent Development Table 113. Zhejiang Xianju Pharmaceutical Company Information Table 114. Zhejiang Xianju Pharmaceutical Business Overview Table 115. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio Table 117. Zhejiang Xianju Pharmaceutical Recent Development Table 118. North America Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 120. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026) Table 121. North America Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Long-Acting Contraceptive Pills Sales Market Share Forecast by Country (2027-2032) Table 123. North America Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Long-Acting Contraceptive Pills Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Long-Acting Contraceptive Pills Market Share by Country (2021-2026) Table 126. North America Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Long-Acting Contraceptive Pills Market Share Forecast by Country (2027-2032) Table 128. Europe Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 130. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026) Table 131. Europe Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Long-Acting Contraceptive Pills Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Long-Acting Contraceptive Pills Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Long-Acting Contraceptive Pills Market Share by Country (2021-2026) Table 136. Europe Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Long-Acting Contraceptive Pills Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Long-Acting Contraceptive Pills Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Long-Acting Contraceptive Pills Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Long-Acting Contraceptive Pills Market Share by Country (2021-2026) Table 146. Asia-Pacific Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Long-Acting Contraceptive Pills Market Share Forecast by Country (2027-2032) Table 148. Latin America Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 150. Latin America Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026) Table 151. Latin America Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Long-Acting Contraceptive Pills Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Long-Acting Contraceptive Pills Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Long-Acting Contraceptive Pills Market Share by Country (2021-2026) Table 156. Latin America Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Long-Acting Contraceptive Pills Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Long-Acting Contraceptive Pills Market Share by Country (2021-2026) Table 166. Middle East and Africa Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Long-Acting Contraceptive Pills Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Long-Acting Contraceptive Pills Distributors List Table 171. Long-Acting Contraceptive Pills Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Long-Acting Contraceptive Pills Image Figure 2. Global Long-Acting Contraceptive Pills Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Acting Contraceptive Pills Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-Acting Contraceptive Pills Sales (2021-2032) & (K Units) Figure 5. Injectables Image Figure 6. Global Injectables Sales YoY Growth (2021-2032) & (K Units) Figure 7. Subdermal Implants Image Figure 8. Global Subdermal Implants Sales YoY Growth (2021-2032) & (K Units) Figure 9. Intrauterine Devices Image Figure 10. Global Intrauterine Devices Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Long-Acting Contraceptive Pills Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Long-Acting Contraceptive Pills Market Share by Type 2025 VS 2032 Figure 15. North America Long-Acting Contraceptive Pills Sales Market Share in Volume by Type in 2025 Figure 16. North America Long-Acting Contraceptive Pills Sales Market Share in Value by Type in 2025 Figure 17. Europe Long-Acting Contraceptive Pills Sales Market Share in Volume by Type in 2025 Figure 18. Europe Long-Acting Contraceptive Pills Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Long-Acting Contraceptive Pills Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Long-Acting Contraceptive Pills Sales Market Share in Value by Type in 2025 Figure 21. Latin America Long-Acting Contraceptive Pills Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Long-Acting Contraceptive Pills Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Long-Acting Contraceptive Pills Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Long-Acting Contraceptive Pills Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Long-Acting Contraceptive Pills Market Share by Application 2025 VS 2032 Figure 33. North America Long-Acting Contraceptive Pills Sales Market Share in Volume by Application in 2025 Figure 34. North America Long-Acting Contraceptive Pills Sales Market Share in Value by Application in 2025 Figure 35. Europe Long-Acting Contraceptive Pills Sales Market Share in Volume by Application in 2025 Figure 36. Europe Long-Acting Contraceptive Pills Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Long-Acting Contraceptive Pills Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Long-Acting Contraceptive Pills Sales Market Share in Value by Application in 2025 Figure 39. Latin America Long-Acting Contraceptive Pills Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Long-Acting Contraceptive Pills Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share in Value by Application in 2025 Figure 43. North America Long-Acting Contraceptive Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Long-Acting Contraceptive Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Long-Acting Contraceptive Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Long-Acting Contraceptive Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Long-Acting Contraceptive Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Long-Acting Contraceptive Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Long-Acting Contraceptive Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Long-Acting Contraceptive Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Long-Acting Contraceptive Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Long-Acting Contraceptive Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Long-Acting Contraceptive Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Long-Acting Contraceptive Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Long-Acting Contraceptive Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Long-Acting Contraceptive Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Long-Acting Contraceptive Pills Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Long-Acting Contraceptive Pills Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables
  • Subdermal Implants
  • Intrauterine Devices
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Bayer
  • Cipla
  • Merck
  • Sun Pharma
  • Teva Pharmaceuticals
  • Pfizer
  • Mylan
  • Shanghai Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Long-Acting Contraceptive Pills Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Long-Acting Contraceptive Pills Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Long-Acting Contraceptive Pills Market by Type
  6. 1.3.1 Injectables
  7. 1.3.2 Subdermal Implants
  8. 1.3.3 Intrauterine Devices
  9. 1.3.4 Other
  10. 1.4 Global Long-Acting Contraceptive Pills Market Size by Type
  11. 1.4.1 Global Long-Acting Contraceptive Pills Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Long-Acting Contraceptive Pills Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Long-Acting Contraceptive Pills Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Long-Acting Contraceptive Pills Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Long-Acting Contraceptive Pills Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Long-Acting Contraceptive Pills Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Long-Acting Contraceptive Pills Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Long-Acting Contraceptive Pills Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Long-Acting Contraceptive Pills Industry Trends
  2. 2.2 Long-Acting Contraceptive Pills Industry Drivers
  3. 2.3 Long-Acting Contraceptive Pills Industry Opportunities and Challenges
  4. 2.4 Long-Acting Contraceptive Pills Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Long-Acting Contraceptive Pills Revenue (2021-2026)
  2. 3.2 Global Top Players by Long-Acting Contraceptive Pills Sales (2021-2026)
  3. 3.3 Global Top Players by Long-Acting Contraceptive Pills Price (2021-2026)
  4. 3.4 Global Long-Acting Contraceptive Pills Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-Acting Contraceptive Pills Major Company Production Sites & Headquarters
  6. 3.6 Global Long-Acting Contraceptive Pills Company, Product Type & Application
  7. 3.7 Global Long-Acting Contraceptive Pills Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-Acting Contraceptive Pills Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-Acting Contraceptive Pills Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-Acting Contraceptive Pills Tier 1, Tier 2, and Tier 3
4 Long-Acting Contraceptive Pills Regional Status and Outlook
  1. 4.1 Global Long-Acting Contraceptive Pills Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Long-Acting Contraceptive Pills Historic Market Size by Region
  3. 4.2.1 Global Long-Acting Contraceptive Pills Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Long-Acting Contraceptive Pills Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Long-Acting Contraceptive Pills Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Long-Acting Contraceptive Pills Forecasted Market Size by Region
  7. 4.3.1 Global Long-Acting Contraceptive Pills Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Long-Acting Contraceptive Pills Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Long-Acting Contraceptive Pills Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Long-Acting Contraceptive Pills by Application
  1. 5.1 Long-Acting Contraceptive Pills Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Long-Acting Contraceptive Pills Market Size by Application
  5. 5.2.1 Global Long-Acting Contraceptive Pills Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Long-Acting Contraceptive Pills Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Long-Acting Contraceptive Pills Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Long-Acting Contraceptive Pills Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Long-Acting Contraceptive Pills Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Long-Acting Contraceptive Pills Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Long-Acting Contraceptive Pills Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Long-Acting Contraceptive Pills Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer
  2. 6.1.1 Bayer Company Information
  3. 6.1.2 Bayer Business Overview
  4. 6.1.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
  6. 6.1.5 Bayer Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Long-Acting Contraceptive Pills Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Sun Pharma
  20. 6.4.1 Sun Pharma Company Information
  21. 6.4.2 Sun Pharma Business Overview
  22. 6.4.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
  24. 6.4.5 Sun Pharma Recent Developments
  25. 6.5 Teva Pharmaceuticals
  26. 6.5.1 Teva Pharmaceuticals Company Information
  27. 6.5.2 Teva Pharmaceuticals Business Overview
  28. 6.5.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  30. 6.5.5 Teva Pharmaceuticals Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Shanghai Pharmaceuticals
  44. 6.8.1 Shanghai Pharmaceuticals Company Information
  45. 6.8.2 Shanghai Pharmaceuticals Business Overview
  46. 6.8.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  48. 6.8.5 Shanghai Pharmaceuticals Recent Developments
  49. 6.9 Zhejiang Xianju Pharmaceutical
  50. 6.9.1 Zhejiang Xianju Pharmaceutical Company Information
  51. 6.9.2 Zhejiang Xianju Pharmaceutical Business Overview
  52. 6.9.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
  54. 6.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Long-Acting Contraceptive Pills Sales by Country
  2. 7.1.1 North America Long-Acting Contraceptive Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Long-Acting Contraceptive Pills Sales by Country (2021-2026)
  4. 7.1.3 North America Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032)
  5. 7.2 North America Long-Acting Contraceptive Pills Market Size by Country
  6. 7.2.1 North America Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Long-Acting Contraceptive Pills Market Size by Country (2021-2026)
  8. 7.2.3 North America Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Long-Acting Contraceptive Pills Sales by Country
  2. 8.1.1 Europe Long-Acting Contraceptive Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026)
  4. 8.1.3 Europe Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Long-Acting Contraceptive Pills Market Size by Country
  6. 8.2.1 Europe Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Long-Acting Contraceptive Pills Market Size by Country (2021-2026)
  8. 8.2.3 Europe Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Long-Acting Contraceptive Pills Sales by Country
  2. 9.1.1 Asia-Pacific Long-Acting Contraceptive Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Long-Acting Contraceptive Pills Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Long-Acting Contraceptive Pills Market Size by Country
  6. 9.2.1 Asia-Pacific Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Long-Acting Contraceptive Pills Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Long-Acting Contraceptive Pills Sales by Country
  2. 10.1.1 South America Long-Acting Contraceptive Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Long-Acting Contraceptive Pills Sales by Country (2021-2026)
  4. 10.1.3 South America Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032)
  5. 10.2 South America Long-Acting Contraceptive Pills Market Size by Country
  6. 10.2.1 South America Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Long-Acting Contraceptive Pills Market Size by Country (2021-2026)
  8. 10.2.3 South America Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country
  2. 11.1.1 Middle East and Africa Long-Acting Contraceptive Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country
  6. 11.2.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Long-Acting Contraceptive Pills Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Long-Acting Contraceptive Pills Value Chain Analysis
  2. 12.1.1 Long-Acting Contraceptive Pills Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Long-Acting Contraceptive Pills Production Mode & Process
  7. 12.2 Long-Acting Contraceptive Pills Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Long-Acting Contraceptive Pills Distributors
  10. 12.2.3 Long-Acting Contraceptive Pills Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst